These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29685206)

  • 81. Morphometric analysis of axons in the minute multiple sclerosis lesions and shadow plaques in patients with multiple sclerosis.
    Nowacki P; Potemkowski A; Korwin-Piotrowska T; Nocoń D
    Folia Neuropathol; 2000; 38(3):104-10. PubMed ID: 11043971
    [TBL] [Abstract][Full Text] [Related]  

  • 82. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.
    Tauhid S; Neema M; Healy BC; Weiner HL; Bakshi R
    J Neurol Sci; 2014 Nov; 346(1-2):250-4. PubMed ID: 25220114
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Chaos theory for clinical manifestations in multiple sclerosis.
    Akaishi T; Takahashi T; Nakashima I
    Med Hypotheses; 2018 Jun; 115():87-93. PubMed ID: 29685206
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Clinical subtypes of multiple sclerosis and the immuno-pathogeneses].
    Fujihara K
    Nihon Rinsho; 2003 Aug; 61(8):1293-9. PubMed ID: 12962014
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Immunological differences between classical phenothypes of multiple sclerosis.
    Iwanowski P; Losy J
    J Neurol Sci; 2015 Feb; 349(1-2):10-4. PubMed ID: 25586536
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Immunology of relapse and remission in multiple sclerosis.
    Steinman L
    Annu Rev Immunol; 2014; 32():257-81. PubMed ID: 24438352
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Pathology and definition of multiple sclerosis].
    Dutta R; Trapp BD
    Rev Prat; 2006 Jun; 56(12):1293-8. PubMed ID: 16948216
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.
    Bates D
    Neurology; 2011 Jan; 76(1 Suppl 1):S14-25. PubMed ID: 21205678
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Influence of Peripheral inflammation on the progression of multiple sclerosis: evidence from the clinic and experimental animal models.
    Murta V; Ferrari CC
    Mol Cell Neurosci; 2013 Mar; 53():6-13. PubMed ID: 22771835
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Association between seasonal factors and multiple sclerosis.
    Watad A; Azrielant S; Soriano A; Bracco D; Abu Much A; Amital H
    Eur J Epidemiol; 2016 Nov; 31(11):1081-1089. PubMed ID: 27226079
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis.
    Fox EJ
    Expert Rev Neurother; 2010 Dec; 10(12):1789-97. PubMed ID: 21091310
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
    Karussis D
    J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Brain atrophy: an in-vivo measure of disease activity in multiple sclerosis.
    Radü EW; Bendfeldt K; Mueller-Lenke N; Magon S; Sprenger T
    Swiss Med Wkly; 2013; 143():w13887. PubMed ID: 24264439
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pathology of multiple sclerosis and related inflammatory demyelinating diseases.
    Kutzelnigg A; Lassmann H
    Handb Clin Neurol; 2014; 122():15-58. PubMed ID: 24507512
    [TBL] [Abstract][Full Text] [Related]  

  • 95. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.
    Filippi M; Rocca MA
    J Neurol; 2005 Nov; 252 Suppl 5():v16-24. PubMed ID: 16254697
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Therapy of multiple sclerosis].
    Simó M
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Treating relapsing-remitting multiple sclerosis: therapy effects on brain atrophy.
    Vidal-Jordana A; Sastre-Garriga J; Rovira A; Montalban X
    J Neurol; 2015 Dec; 262(12):2617-26. PubMed ID: 26041617
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Central nervous system atrophy and clinical status in multiple sclerosis.
    Zivadinov R; Bakshi R
    J Neuroimaging; 2004 Jul; 14(3 Suppl):27S-35S. PubMed ID: 15228757
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Early accurate diagnosis crucial in multiple sclerosis.
    Tur C; Thompson AJ
    Practitioner; 2015 Sep; 259(1785):21-7, 2-3. PubMed ID: 26591653
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.